Aug 16, 2021 / 08:30PM GMT
Operator
Good afternoon, and welcome to the INVO Bioscience second-quarter fiscal year 2021 financial results conference call. All participants will be in listen-only mode. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.
Robert Blum - Lytham Partners, LLC - IR
Thanks very much, Gary, and good afternoon, everyone. Thank you all for joining us for today's INVO Bioscience's second-quarter 2021 financial results conference call. Joining us on the call today is Steve Shum, INVO Bioscience's Chief Executive Officer; the company's Chief Operating Officer and VP of Business Development, Mike Campbell; and the company's Chief Financial Officer, Andrea Goren. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Before we begin with the event, we submit for the record the following statements. Certain matters discussed on this conference call by management of INVO Bioscience may be forward-looking
Q2 2021 INVO Bioscience Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
